VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,031 | -18.9% | 25,933 | +23.7% | 0.00% | – |
| Q2 2023 | $138,100 | +2.8% | 20,956 | +6.0% | 0.00% | – |
| Q1 2023 | $134,279 | +1.8% | 19,776 | +10.8% | 0.00% | – |
| Q4 2022 | $131,867 | +18.8% | 17,844 | +59.2% | 0.00% | – |
| Q3 2022 | $111,000 | +0.9% | 11,210 | +11.4% | 0.00% | – |
| Q2 2022 | $110,000 | -34.5% | 10,064 | -5.9% | 0.00% | – |
| Q4 2021 | $168,000 | -12.5% | 10,698 | -8.4% | 0.00% | – |
| Q4 2019 | $192,000 | +34.3% | 11,685 | +8.2% | 0.00% | – |
| Q3 2019 | $143,000 | -2.1% | 10,796 | +4.3% | 0.00% | – |
| Q2 2019 | $146,000 | -21.9% | 10,352 | +1.6% | 0.00% | – |
| Q1 2019 | $187,000 | – | 10,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |